Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04629963 · ClinicalTrials.gov registry record · NA
Chronic Pain Diagnosis and Treatment in Torture Survivors
A NA study of Pain and Pain, Chronic, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT04629963: Recruiting NA study of Pain and Pain, Chronic, sponsored by Weill Medical College of Cornell University.
NCT04629963 is a NA study of Pain and Pain, Chronic that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 100 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04629963, a NA study of Pain and Pain, Chronic, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal Aim 1 of this investigation is to characterize the diagnosis of chronic pain in torture survivors. The investigators hypothesize that using a validated pain screen to supplement the existing United Nations Istanbul Protocol can improve the ability to detect pain from 15% to 90% in this study population. Investigators will test this hypothesis by conducting a prospective, blind comparison to gold standard study. The goal of Aim 2 is to evaluate the acceptability of somatic pain treatment using qualitative interviews of torture survivors. The goal of Aim 3 is to assess the feasibility of recruiting and retaining participants in a digital pain program over six months.
Primary Outcome
The UNIP results in a binary "yes" or "no" clinical pain diagnosis by the evaluator.
Conditions Studied
Interventions
- OTHER Pain Evaluation and BPISF
- OTHER Surveys, a fingerstick blood sample, EMAs, and a digital wearable device
Study Locations (4)
New York
- Bellevue/New York University Program for Survivors of Torture - New York
- Mount Sinai Human Rights Program - New York
- Columbia University Human Rights Initiative and Asylum Clinic - New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT04629963 shows while recruiting
NCT04629963 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Pain Evaluation and BPISF is the first listed.
NCT04629963 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04629963 about?
NCT04629963 is a clinical study titled "Chronic Pain Diagnosis and Treatment in Torture Survivors". The goal Aim 1 of this investigation is to characterize the diagnosis of chronic pain in torture survivors. The investigators hypothesize that using a validated pain screen to supplement the existing United Nations Istanbul Protocol can improve the ability to detect pain from 15% to 90% in this stud...
What is the current status of trial NCT04629963?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-14. Estimated completion is 2026-01-31.
What conditions does trial NCT04629963 study?
This clinical trial studies the following conditions: Pain, Pain, Chronic.
What interventions are being tested in trial NCT04629963?
The interventions under investigation include: Pain Evaluation and BPISF (OTHER), Surveys, a fingerstick blood sample, EMAs, and a digital wearable device (OTHER).
Who is sponsoring clinical trial NCT04629963?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04629963 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04629963's enrollment target sits among peer trials
100 164th of 374 higher than 201 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI